Most people are aware of hepatitis C, but other types of viral hepatitis and liver disease often get overlooked. As a result, Americans suffer.
Every 30 seconds a person dies from a hepatitis-related illness. That startling statistic underscores the urgency to test, treat and cure people with viral hepatitis, who often face dangerous delays.
Across the country, state Medicaid programs are improving patients’ chances of being cured of hepatitis C. If more states follow suit, the deadly virus could be eliminated this decade.
After years of steadily increasing hepatitis rates, the country has lost its way on controlling the deadly viral disease. Now, it has a new map.
Holes in clinical trials data could be keeping people of color from accessing the medication they need.
Years after a cure became available for hepatitis C, infections are skyrocketing.
Good intentions are having unintended consequences for hepatitis C patients in California.
When it comes to curing hepatitis C, the United States is at the bottom of the barrel.
While some hepatitis C patients stateside are rejoicing at newly-relaxed barriers to curative treatment, those covered by Medicaid in Puerto Rico must watch and wait.
Two new publications point to the value of treating hepatitis C – early, aggressively and alongside heightened screening efforts.